3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
4
Inositol
3
drospirenone and ethinyl estradiol combination
2
Progesterone
2
Folic Acid
2
Ethinyl Estradiol
2
Cyproterone Acetate
2
salicylsalicylic acid
1
maltodextrin
1
licogliflozin
1
Yoga
1
Waist-Hip Ratio
1
Waist Circumference
1
Time
1
Thioctic Acid
1
Sugars
1
Spironolactone
1
Sodium Salicylate
1
Phlebotomy
1
Lactalbumin
1
Inulin
1
Insulin
1
Glycoprotein Hormones, alpha Subunit
1
Flutamide
1
Estrogens
1
Estradiol
1
Doxycycline
1
Clomiphene
1
Cardiovascular Physiological Phenomena
1
Body Mass Index
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hyperandrogenism
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts